Amid raging debate over the cost of insulin, a new report finds prices in the U.S. were often five to 10 times higher two years ago than in all the other countries in the Organization for Economic Cooperation and Development (OECD), an intergovernmental group that was created to stimulate economic progress and world trade. In 2018, the average U.S. price per standard unit across all types of insulin was $98.70, compared with $6.94 in Australia, $12.00 in Canada, $7.52 in the U.K. and $8.81 across all other OECD countries combined, according to the report by the RAND Corp., which conducted the analysis on behalf of the Department of Health and Human Services Office of the Assistant Secretary for Planning and Evaluation.
